Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells. | Cancers (Basel) | 2021 | 33917317 | PubTator, text mining | PubMed |
| N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | Int J Mol Sci | 2021 | 33916271 | PubTator, text mining | PubMed |
| Regulation of metastasis suppressor NME1 by a key metabolic cofactor coenzyme A. | Redox Biol | 2021 | 33903070 | Swiss-Prot, curated | PubMed |
| Rethinking the biology of metastatic melanoma: a holistic approach. | Cancer Metastasis Rev | 2021 | 33870460 | PubTator, text mining | PubMed |
| Quantitative Proteomic Analysis in Alveolar Type II Cells Reveals the Different Capacities of RAS and TGF-β to Induce Epithelial-Mesenchymal Transition. | Front Mol Biosci | 2021 | 33869273 | PubTator, text mining | PubMed |
| Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD. | Hepatol Commun | 2021 | 33860118 | PubTator, text mining | PubMed |
| NM23-H1 Expression of Head and Neck Squamous Cell Carcinoma in Association With the Response to Irradiation. | Front Oncol | 2021 | 33859945 | PubTator, text mining | PubMed |
| Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas. | Front Pharmacol | 2021 | 33841137 | PubTator, text mining | PubMed |
| NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer. | J Exp Clin Cancer Res | 2021 | 33838681 | PubTator, text mining | PubMed |
| Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review. | World J Virol | 2021 | 33816150 | PubTator, text mining | PubMed |
| Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives. | Cancers (Basel) | 2021 | 33808624 | PubTator, text mining | PubMed |
| Changes in Biomechanical Properties of A375 Cells Due to the Silencing of TMSB4X Expression Are Not Directly Correlated with Alterations in Their Stemness Features. | Cells | 2021 | 33807338 | PubTator, text mining | PubMed |
| The Roadmap of Colorectal Cancer Screening. | Cancers (Basel) | 2021 | 33806465 | PubTator, text mining | PubMed |
| Relevance of 2'-O-Methylation and Pseudouridylation for the Malignant Melanoma. | Cancers (Basel) | 2021 | 33803145 | PubTator, text mining | PubMed |
| Emerging Molecular Connections between NM23 Proteins, Telomeres and Telomere-Associated Factors: Implications in Cancer Metastasis and Ageing. | Int J Mol Sci | 2021 | 33801585 | PubTator, text mining | PubMed |
| A noncanonical microRNA derived from the snaR-A noncoding RNA targets a metastasis inhibitor. | RNA | 2021 | 33795480 | PubTator, text mining | PubMed |
| LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels. | Oncol Rep | 2021 | 33786631 | PubTator, text mining | PubMed |
| Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer. | Front Oncol | 2021 | 33777753 | PubTator, text mining | PubMed |
| Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer. | BMC Cancer | 2021 | 33761899 | PubTator, text mining | PubMed |
| Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation. | Exp Mol Med | 2021 | 33753879 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=32